Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade D 7.07 3.82% 0.26
OPTN closed up 3.82 percent on Tuesday, October 15, 2019, on 86 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical OPTN trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
50 DMA Support Bullish 3.82%
Wide Bands Range Expansion 3.82%
Crossed Above 50 DMA Bullish 3.51%
Wide Bands Range Expansion 3.51%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 10.30%
Narrow Range Bar Range Contraction 10.30%
NR7 Range Contraction 10.30%

Older signals for OPTN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
OPTN Chart by TradingView
Basic chart:
Profile
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Medicine Pharmaceutical Clinical Medicine Organ Systems Disease Inflammation Respiratory Therapy Allergy Glucocorticoids Sinusitis
Is OPTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 4 Optinose Appoints Michael Richardson to New Position of Vice President, Business Development
Sep 27 Optinose to Present at the 2019 Cantor Global Healthcare Conference
Sep 26 Currax™ Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail®
Sep 26 OptiNose out-licenses Onzetra Xsail to Currax Pharma
Sep 26 OptiNose Announces License Agreement Related to ONZETRA XSAIL
Sep 17 Optinose commercial chief bids adieu
Sep 17 Optinose Announces Departure of Chief Commercial Officer
Sep 12 OptiNose secures $150M in new debt capital
Sep 12 Optinose Announces $150 Million Debt Financing from Pharmakon
Sep 11 Is OptiNose (NASDAQ:OPTN) Using Debt In A Risky Way?
See more OPTN news...
Indicators
Indicator Value
52 Week High 12.05
52 Week Low 4.4431
Average Volume 254,695
200-Day Moving Average 7.6471
50-Day Moving Average 6.7567
20-Day Moving Average 7.0803
10-Day Moving Average 6.558
Average True Range 0.4502
ADX 18.44
+DI 22.5621
-DI 18.456
Chandelier Exit (Long, 3 ATRs ) 7.2194
Chandelier Exit (Short, 3 ATRs ) 7.3606
Upper Bollinger Band 8.3319
Lower Bollinger Band 5.8287
Percent B (%b) 0.5
BandWidth 35.354434
MACD Line -0.0992
MACD Signal Line -0.0756
MACD Histogram -0.0236
Fundamentals Value
Market Cap 266.97 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -0.36
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.60
Resistance 3 (R3) 7.56 7.36 7.51
Resistance 2 (R2) 7.36 7.22 7.37 7.48
Resistance 1 (R1) 7.21 7.14 7.29 7.25 7.45
Pivot Point 7.01 7.01 7.04 7.02 7.01
Support 1 (S1) 6.86 6.87 6.94 6.90 6.69
Support 2 (S2) 6.66 6.79 6.67 6.66
Support 3 (S3) 6.51 6.66 6.63
Support 4 (S4) 6.55